404 related articles for article (PubMed ID: 21592751)
21. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
22. Preparation of orally disintegrating tablets with taste-masking function: masking effect in granules prepared with correctives using the dry granulation method and evaluation of tablets prepared using the taste-masked granules.
Kawano Y; Ito A; Sasatsu M; Machida Y
Yakugaku Zasshi; 2010 Jan; 130(1):81-6. PubMed ID: 20046070
[TBL] [Abstract][Full Text] [Related]
23. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
Ge Z; Yang M; Wang Y; Shan L; Gao C
Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
[TBL] [Abstract][Full Text] [Related]
24. Impact of active ingredients on the swelling properties of orally disintegrating tablets prepared by microwave treatment.
Sano S; Iwao Y; Kimura S; Noguchi S; Itai S
Int J Pharm; 2014 Jul; 468(1-2):234-42. PubMed ID: 24709215
[TBL] [Abstract][Full Text] [Related]
25. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets.
Nakano Y; Maeda A; Uchida S; Namiki N
Int J Pharm; 2013 Mar; 446(1-2):160-5. PubMed ID: 23419665
[TBL] [Abstract][Full Text] [Related]
26. Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods.
Kashiwagura Y; Takusagawa S; Ikematsu Y; Tanaka S; Namiki N; Uchida S
Acta Pharm; 2023 Mar; 73(1):107-119. PubMed ID: 36692467
[TBL] [Abstract][Full Text] [Related]
27. [Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method].
Kawano Y; Ito A; Sasatsu M; Machida Y; Onishi H
Yakugaku Zasshi; 2010 Dec; 130(12):1737-42. PubMed ID: 21139401
[TBL] [Abstract][Full Text] [Related]
28. Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets.
Kimura S; Uchida S; Kanada K; Namiki N
Int J Pharm; 2015 Apr; 484(1-2):156-62. PubMed ID: 25681720
[TBL] [Abstract][Full Text] [Related]
29. Improvement of dissolution and tabletability of carbamazepine solid dispersions with high drug loading prepared by hot-melt extrusion.
Feng Z; Li M; Wang W
Pharmazie; 2019 Sep; 74(9):523-528. PubMed ID: 31484591
[TBL] [Abstract][Full Text] [Related]
30. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
31. Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants.
Goel H; Tiwary AK; Rana V
Acta Pol Pharm; 2011; 68(4):571-83. PubMed ID: 21796940
[TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of orally disintegrating tablets containing vitamin E as a model fat-soluble drug.
Ikematsu Y; Uchida S; Namiki N
Chem Pharm Bull (Tokyo); 2015; 63(3):156-63. PubMed ID: 25757486
[TBL] [Abstract][Full Text] [Related]
33. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
Wang L; Zeng F; Zong L
Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
[TBL] [Abstract][Full Text] [Related]
34. An in-vivo and in-vitro taste masking evaluation of bitter melt-extruded drugs.
Maniruzzaman M; Bonnefille M; Aranyos A; Snowden MJ; Douroumis D
J Pharm Pharmacol; 2014 Feb; 66(2):323-37. PubMed ID: 24180412
[TBL] [Abstract][Full Text] [Related]
35. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
[TBL] [Abstract][Full Text] [Related]
36. Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes.
Kidokoro M; Shah NH; Malick AW; Infeld MH; McGinity JW
Pharm Dev Technol; 2001; 6(2):263-75. PubMed ID: 11417001
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
39. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
[TBL] [Abstract][Full Text] [Related]
40. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
Devireddy SR; Gonugunta CS; Veerareddy PR
PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]